U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07526675) titled 'Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer' on March 27.
Brief Summary: This prospective study aims to validate the clinical outcomes of performing a concomitant trans-perineal prostate biopsy and laser ablation (termed "Bioblation") during a single session. The intervention is designed for symptomatic patients presenting with lower urinary tract symptoms (LUTS) who are highly suspected to have low to favorable intermediate-risk prostate cancer. By combining diagnosis and targeted treatment under local anesthesia, this approach seeks to facilitate early relief of severe symptoms and a r...